These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Ventricular tachycardias induced by intracoronary administration of endothelin-1 in dogs. Tóth M; Solti F; Merkely B; Kékesi V; Horkay F; Szokodi I; Juhász-Nagy A J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S153-5. PubMed ID: 8587349 [TBL] [Abstract][Full Text] [Related]
12. The selective endothelin-A-receptor antagonist LU 135.252 inhibits the direct arrhythmogenic action of endothelin-1. Merkely B; Szabó T; Gellér L; Kiss O; Horkay F; Raschack M; Juhász-Nagy A J Cardiovasc Pharmacol; 2000 Nov; 36(5 Suppl 1):S314-6. PubMed ID: 11078407 [TBL] [Abstract][Full Text] [Related]
13. Characterization of canine pericardial fluid endothelin-1 levels. Szokodi I; Horkay F; Kiss P; Selmeci L; Horváth I; Vuolteenaho O; Ruskoaho H; Juhász-Nagy A; Tóth M J Cardiovasc Pharmacol; 1998; 31 Suppl 1():S399-400. PubMed ID: 9595495 [TBL] [Abstract][Full Text] [Related]
14. Investigating the dual nature of endothelin-1: ischemia or direct arrhythmogenic effect? Szabó T; Gellér L; Merkely B; Selmeci L; Juhász-Nagy A; Solti F Life Sci; 2000 May; 66(26):2527-41. PubMed ID: 10883731 [TBL] [Abstract][Full Text] [Related]
15. Effects of experimental diabetes on endothelin-induced ventricular arrhythmias in dogs. Pósa I; Horkay F; Seres L; Skoumal R; Kováts T; Balogh E; de Châtel R; Tóth M; Kocsis E J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S380-2. PubMed ID: 15838325 [TBL] [Abstract][Full Text] [Related]
16. Intrapericardial adenine nucleosides induce elevation of endothelin-1 concentration in the pericardial space of the dog heart. Nagy A; Toma I; Rusvai M; Barát E; Huszár E; Juhász-Nagy A; Kékesi V J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S227-30. PubMed ID: 15838286 [TBL] [Abstract][Full Text] [Related]
17. Effects of intrapericardially administered endothelin-1 on pericardial natriuretic peptide concentrations of the in situ dog heart. Toma I; Nagy A; Jánosi C; Rusvai M; Juhász-Nagy A; Kékesi V J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S231-3. PubMed ID: 15838287 [TBL] [Abstract][Full Text] [Related]
18. Intracoronary endothelin-1 infusion combined with systemic isoproterenol treatment: antagonistic arrhythmogenic effects. Kiss O; Zima E; Soós P; Kékesi V; Juhász-Nagy A; Merkely B Life Sci; 2004 Jun; 75(5):537-48. PubMed ID: 15158364 [TBL] [Abstract][Full Text] [Related]
19. Effects of endothelin-1 and the ETA-receptor antagonist, BQ123, on ischemic arrhythmias in anesthetized rats. Garjani A; Wainwright CL; Zeitlin IJ; Wilson C; Slee SJ J Cardiovasc Pharmacol; 1995 Apr; 25(4):634-42. PubMed ID: 7596133 [TBL] [Abstract][Full Text] [Related]
20. A prospective study of the effect of I.V. pentamidine therapy on ventricular arrhythmias and QTc prolongation in HIV-infected patients. Girgis I; Gualberti J; Langan L; Malek S; Mustaciuolo V; Costantino T; McGinn TG Chest; 1997 Sep; 112(3):646-53. PubMed ID: 9315796 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]